No survival benefit of chemotherapy escalation in patients with pCR and 'high-immune' triple-negative early breast cancer in the neoadjuvant WSG-ADAPT-TN trial
2019
Online
unknown
Zugriff:
Titel: |
No survival benefit of chemotherapy escalation in patients with pCR and 'high-immune' triple-negative early breast cancer in the neoadjuvant WSG-ADAPT-TN trial
|
---|---|
Autor/in / Beteiligte Person: | Gluz, O ; Nitz, U ; Liedtke, C ; Prat, A ; Christgen, M ; Feuerhake, F ; Garke, M ; Grischke, E-M ; Forstbauer, H ; Braun, M ; Warm, M ; Hackmann, J ; Uleer, C ; Aktas, B ; Schumacher, C ; Kümmel, Sherko ; Pelz, E ; Gebauer, D ; Paré, L ; Kates, R ; Wuerstlein, R ; Kreipe, HH ; Harbeck, N |
Link: | |
Veröffentlichung: | 2019 |
Medientyp: | unknown |
Schlagwort: |
|
Sonstiges: |
|